Analyst Consensus ?
ConsensusBuy58 ratings
Bullish3967.3%
Neutral1831.0%
Bearish11.7%
FN2 Earnings Intelligence
Gilead Sciences, Inc. analyst ratings
Gilead Sciences, Inc. (GILD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$143.72Current
$54Low
$122.13Average
$180High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| HSBC | Buy | Buy | Maintain | Sep 10, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 5, 2026 |
| Needham | Buy | Buy | Maintain | Aug 5, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 27, 2026 |
| Leerink Partners | Market Perform | Outperform | Downgrade | Jul 21, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 7, 2026 |
| Maxim Group | Buy | Hold | Upgrade | May 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Feb 11, 2026 |
| UBS | Buy | Buy | Maintain | Jan 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 31, 2025 |
| TD Cowen | Buy | Buy | Maintain | Oct 23, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 8, 2025 |
| Mizuho | Outperform | Outperform | Maintain | May 5, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 25, 2025 |
| B of A Securities | Buy | Buy | Maintain | Mar 5, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Feb 18, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 12, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Feb 12, 2025 |
| Baird | Neutral | Neutral | Maintain | Feb 12, 2025 |
| Raymond James | Outperform | Market Perform | Upgrade | Jul 8, 2024 |
| Benchmark | Buy | Buy | Maintain | Aug 8, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 6, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Feb 3, 2023 |
| Argus Research | Buy | Hold | Upgrade | Jan 28, 2022 |
| Bernstein | Outperform | Market Perform | Upgrade | Apr 1, 2021 |
| Redburn Partners | Buy | Neutral | Upgrade | Mar 30, 2021 |
| Redburn | Buy | Neutral | Upgrade | Mar 30, 2021 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 5, 2021 |
| SunTrust Robinson Humphrey | Hold | Sell | Upgrade | May 26, 2020 |
| CFRA | Sell | Sell | Maintain | Apr 29, 2020 |
| DZ Bank | Buy | Hold | Upgrade | Mar 18, 2020 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Jan 21, 2020 |
| Guggenheim | Neutral | Buy | Downgrade | Jan 21, 2020 |
| Longbow Research | Neutral | Buy | Downgrade | Apr 16, 2019 |
| PiperJaffray | Neutral | Overweight | Downgrade | Oct 26, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Feb 7, 2018 |
| Bank of America | Neutral | Neutral | Maintain | Feb 7, 2018 |
| Jefferies | Buy | Hold | Upgrade | Jan 26, 2018 |
| Summit Redstone Partners | Hold | Hold | Maintain | Dec 1, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 14, 2016 |
| Berenberg | Buy | Buy | Maintain | Sep 22, 2016 |
| Gabelli & Co. | Buy | Buy | Maintain | Jun 1, 2016 |
| Standpoint Research | Buy | Buy | Maintain | Feb 3, 2016 |
| Atlantic Equities | Neutral | Neutral | Maintain | Dec 18, 2015 |
| Nomura | Buy | Buy | Maintain | Nov 10, 2014 |
| Edward Jones | Hold | Hold | Maintain | Oct 31, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Oct 13, 2014 |
| Topeka | Buy | Buy | Maintain | Jun 10, 2014 |
| Topeka Capital | Buy | Buy | Maintain | Jun 9, 2014 |
| Stifel | Buy | Buy | Maintain | Feb 5, 2014 |
| Sterne Agee | Buy | Buy | Maintain | Jun 25, 2013 |
| Blaylock Robert Van | Buy | Buy | Maintain | Apr 8, 2013 |
| Brigantine | Hold | Buy | Downgrade | Feb 8, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $143.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| HSBC | Morten Herholdt | $175 | $145.65 | +21.8% | Sep 10, 2026 |
| Truist Financial | Analyst unavailable | $150 | $132.76 | +4.4% | Aug 5, 2026 |
| RBC Capital | Analyst unavailable | $123 | $135.25 | -14.4% | Aug 5, 2026 |
| Barclays | Analyst unavailable | $145 | $134.32 | +0.9% | Jul 29, 2026 |
| Morgan Stanley | Analyst unavailable | $165 | $131.23 | +14.8% | Jul 27, 2026 |
| Leerink Partners | Daina Graybosch | $127 | $133.21 | -11.6% | Jul 20, 2026 |
| Morgan Stanley | Analyst unavailable | $166 | $136.36 | +15.5% | Jul 8, 2026 |
| RBC Capital | Brian Abrahams | $120 | $129.61 | -16.5% | Jul 7, 2026 |
| HSBC | Rajesh Kumar | $155 | $131.27 | +7.8% | Jul 6, 2026 |
| RBC Capital | Brian Abrahams | $122 | $134.43 | -15.1% | Jun 1, 2026 |
| Maxim Group | Michael Okunewitch | $165 | $130.55 | +14.8% | May 20, 2026 |
| Morgan Stanley | Analyst unavailable | $168 | $131.33 | +16.9% | May 10, 2026 |
| Truist Financial | Analyst unavailable | $157 | $132.02 | +9.2% | May 8, 2026 |
| Morgan Stanley | Analyst unavailable | $175 | $140.34 | +21.8% | Apr 10, 2026 |
| Truist Financial | Gregory Renza | $155 | $141.54 | +7.8% | Apr 8, 2026 |
| Jefferies | Akash Tewari | $180 | $146.94 | +25.2% | Mar 10, 2026 |
| Barclays | Analyst unavailable | $155 | $151.12 | +7.8% | Feb 19, 2026 |
| Mizuho Securities | Analyst unavailable | $170 | $152.74 | +18.3% | Feb 19, 2026 |
| UBS | Analyst unavailable | $175 | $155.27 | +21.8% | Feb 18, 2026 |
| Scotiabank | Louise Chen | $177 | $155.29 | +23.2% | Feb 11, 2026 |
| Bernstein | Courtney Breen | $160 | $155.45 | +11.3% | Feb 11, 2026 |
| Morgan Stanley | Analyst unavailable | $171 | $155.72 | +19.0% | Feb 11, 2026 |
| Truist Financial | Analyst unavailable | $162 | $155.86 | +12.7% | Feb 11, 2026 |
| Truist Financial | Analyst unavailable | $152 | $154.69 | +5.8% | Feb 11, 2026 |
| Oppenheimer | Analyst unavailable | $165 | $153.46 | +14.8% | Feb 11, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $155 | $147.23 | +7.8% | Feb 11, 2026 |
| Needham | Joseph Stringer | $170 | $154.09 | +18.3% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $145 | $153.89 | +0.9% | Feb 11, 2026 |
| BMO Capital | Evan Seigerman | $160 | $147.23 | +11.3% | Feb 11, 2026 |
| Wells Fargo | Mohit Bansal | $165 | $147.23 | +14.8% | Feb 11, 2026 |
| Truist Financial | Analyst unavailable | $145 | $139.23 | +0.9% | Jan 27, 2026 |
| BMO Capital | Evan David Seigerman | $150 | $137.01 | +4.4% | Jan 26, 2026 |
| UBS | Analyst unavailable | $155 | $136.16 | +7.8% | Jan 26, 2026 |
| Morgan Stanley | Analyst unavailable | $150 | $122.25 | +4.4% | Jan 13, 2026 |
| UBS | Michael Yee | $145 | $121.36 | +0.9% | Jan 7, 2026 |
| Bernstein | Courtney Breen | $135 | $124.56 | -6.1% | Dec 29, 2025 |
| Wolfe Research | Alexandria Hammond | $150 | $120.41 | +4.4% | Dec 15, 2025 |
| Morgan Stanley | Analyst unavailable | $151 | $123.21 | +5.1% | Dec 12, 2025 |
| HSBC | Analyst unavailable | $133 | $119.36 | -7.5% | Dec 10, 2025 |
| BMO Capital | Evan David Seigerman | $135 | $127.57 | -6.1% | Nov 25, 2025 |
| Truist Financial | Gregory Renza | $140 | $127.91 | -2.6% | Nov 24, 2025 |
| Mizuho Securities | Analyst unavailable | $140 | $124.99 | -2.6% | Nov 20, 2025 |
| Morgan Stanley | Terence Flynn | $147 | $118.52 | +2.3% | Oct 31, 2025 |
| RBC Capital | Analyst unavailable | $105 | $118.44 | -26.9% | Oct 31, 2025 |
| Wells Fargo | Analyst unavailable | $145 | $118.44 | +0.9% | Oct 31, 2025 |
| Cantor Fitzgerald | Carter Gould | $135 | $118.25 | -6.1% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $140 | $112.69 | -2.6% | Oct 6, 2025 |
| Deutsche Bank | James Shin | $135 | $118.83 | -6.1% | Aug 11, 2025 |
| Robert W. Baird | Brian Skorney | $108 | $119.41 | -24.9% | Aug 8, 2025 |
| Morgan Stanley | Terence Flynn | $143 | $119.41 | -0.5% | Aug 8, 2025 |
| Leerink Partners | David Risinger | $114 | $112.09 | -20.7% | Jul 14, 2025 |
| Morgan Stanley | Terence Flynn | $135 | $108 | -6.1% | Jun 18, 2025 |
| Cantor Fitzgerald | Carter Gould | $125 | $105.51 | -13.0% | Apr 22, 2025 |
| Morgan Stanley | Terence Flynn | $130 | $114.43 | -9.5% | Mar 11, 2025 |
| Johnson Rice | Analyst unavailable | $126 | $115.44 | -12.3% | Mar 5, 2025 |
| Oppenheimer | Analyst unavailable | $132 | $114.74 | -8.2% | Mar 4, 2025 |
| RBC Capital | Brian Abrahams | $83 | $90.63 | -42.2% | Jan 7, 2025 |
| Piper Sandler | Joseph Catanzaro | $105 | $90.09 | -26.9% | Nov 7, 2024 |
| BMO Capital | Evan David Seigerman | $94 | $86.11 | -34.6% | Oct 21, 2024 |
| Leerink Partners | Andrew Berens | $96 | $86.72 | -33.2% | Oct 21, 2024 |
| Morgan Stanley | Terence Flynn | $84 | $87.07 | -41.6% | Oct 18, 2024 |
| Jefferies | Michael Yee | $95 | $83.76 | -33.9% | Sep 23, 2024 |
| Goldman Sachs | Salveen Richter | $71 | $82.85 | -50.6% | Sep 12, 2024 |
| Morgan Stanley | Terence Flynn | $79 | $82.63 | -45.0% | Sep 12, 2024 |
| Piper Sandler | Joseph Catanzaro | $95 | $79.93 | -33.9% | Sep 11, 2024 |
| Truist Financial | Asthika Goonewardene | $83 | $74.14 | -42.2% | Aug 14, 2024 |
| BMO Capital | Evan David Seigerman | $85 | $75.59 | -40.9% | Aug 9, 2024 |
| RBC Capital | Brian Abrahams | $72 | $75.59 | -49.9% | Aug 9, 2024 |
| Raymond James | Steven Seedhouse | $93 | $67.76 | -35.3% | Jul 8, 2024 |
| Jefferies | Michael Yee | $85 | $71.24 | -40.9% | Jun 24, 2024 |
| Robert W. Baird | Brian Skorney | $80 | $69.21 | -44.3% | Jun 20, 2024 |
| Mizuho Securities | Salim Syed | $90 | $64.52 | -37.4% | Jun 17, 2024 |
| RBC Capital | Brian Abrahams | $74 | $64.68 | -48.5% | Jun 14, 2024 |
| BMO Capital | Evan David Seigerman | $80 | $67.9 | -44.3% | May 20, 2024 |
| HSBC | Morten Herholdt | $69 | $67.08 | -52.0% | Apr 24, 2024 |
| RBC Capital | Brian Abrahams | $76 | $73.53 | -47.1% | Feb 14, 2024 |
| RBC Capital | Brian Abrahams | $84 | $75.9 | -41.6% | Sep 27, 2023 |
| Bank of America Securities | Geoff Meacham | $95 | $75.92 | -33.9% | Sep 8, 2023 |
| Leerink Partners | Analyst unavailable | $91 | $84.64 | -36.7% | Feb 3, 2023 |
| Piper Sandler | Analyst unavailable | $112 | $81.39 | -22.1% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $90 | $85.46 | -37.4% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $81 | $88.34 | -43.6% | Dec 1, 2022 |
| Barclays | Carter Gould | $76 | $79.27 | -47.1% | Oct 31, 2022 |
| Truist Financial | Robyn Karnauskas | $91 | $70.2 | -36.7% | Oct 28, 2022 |
| Robert W. Baird | Brian Skorney | $69 | $79.27 | -52.0% | Oct 28, 2022 |
| Truist Financial | Analyst unavailable | $76 | $64.82 | -47.1% | Sep 15, 2022 |
| Wells Fargo | Analyst unavailable | $74 | $66.19 | -48.5% | Sep 13, 2022 |
| Morgan Stanley | Analyst unavailable | $65 | $62.3 | -54.8% | Jul 15, 2022 |
| Leerink Partners | David Risinger | $68 | $64.04 | -52.7% | May 23, 2022 |
| Piper Sandler | Do Kim | $69 | $63.18 | -52.0% | May 17, 2022 |
| BMO Capital | Analyst unavailable | $63 | $59.54 | -56.2% | Apr 29, 2022 |
| Piper Sandler | Analyst unavailable | $73 | $60.04 | -49.2% | Apr 29, 2022 |
| Piper Sandler | Do Kim | $71 | $60.82 | -50.6% | Apr 6, 2022 |
| Wells Fargo | Mohit Bansal | $63 | $59.45 | -56.2% | Mar 31, 2022 |
| Jefferies | Michael Yee | $80 | $59.5 | -44.3% | Mar 1, 2022 |
| UBS | Colin Bristow | $54 | $59.85 | -62.4% | Feb 24, 2022 |
| Morgan Stanley | Matthew Harrison | $69 | $59.85 | -52.0% | Feb 24, 2022 |
| Mizuho Securities | Salim Syed | $75 | $63.7 | -47.8% | Feb 8, 2022 |
| Atlantic Equities | Steve Chesney | $62 | $63.1 | -56.9% | Feb 4, 2022 |
| Maxim Group | Jason McCarthy | $84 | $64.57 | -41.6% | Feb 3, 2022 |
| Oppenheimer | Hartaj Singh | $90 | $64.57 | -37.4% | Feb 3, 2022 |
| Argus Research | David Toung | $75 | $67.99 | -47.8% | Jan 28, 2022 |
| Goldman Sachs | Salveen Richter | $80 | $67.94 | -44.3% | Dec 6, 2021 |
| Wedbush | Robert Driscoll | $67 | $67.14 | -53.4% | Nov 19, 2021 |
| J.P. Morgan | Cory Kasimov | $74 | $61.14 | -48.5% | Apr 29, 2021 |
Track every rating change on GILD the moment it posts. Free to start.
Start free